Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
1. Characterize the immune response after infection with SARS-CoV-2
Start Date
September 14, 2020
Primary Completion Date
September 14, 2022
Completion Date
September 14, 2022
Last Updated
September 3, 2020
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
Agencia Costarricense de Investigaciones Biomedicas
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions